Insider Transactions in Q1 2023 at Myomo, Inc. (MYO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2023
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+17.2%
|
-
|
|
Mar 08
2023
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+8.61%
|
-
|
|
Mar 08
2023
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+20.16%
|
-
|
|
Mar 08
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+3.29%
|
-
|
|
Mar 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.26%
|
$0
$0.62 P/Share
|
|
Feb 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-0.26%
|
$0
$0.49 P/Share
|
|
Jan 17
2023
|
Micah Mitchell Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
15,384
+19.18%
|
$0
$0.32 P/Share
|
|
Jan 17
2023
|
David A Henry Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
76,923
+31.99%
|
$0
$0.32 P/Share
|
|
Jan 17
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
307,692
+38.9%
|
$0
$0.32 P/Share
|
|
Jan 04
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
139
-0.27%
|
$0
$0.49 P/Share
|